
NYSEHealthcareMedical - Pharmaceuticals
最新数据
US$49.00
+US$0.77 · +1.60%
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
收盘时
US$49.00
+US$0.77 · +1.60%
盘后
US$49.00
US$0.00 · 0.00%
10月12日 16:00 ET
盘中时间采用ET。市场数据可能有所延迟。
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
日内区间
当前US$49.00
52周区间
当前US$49.00
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
83
深度低估
情绪
52
多空交织
风险
42
风险偏高
动量
30
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
日内区间
当前US$49.00
52周区间
当前US$49.00
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 10.89亿 USD | 11.38亿 USD | 11.25亿 USD | 11.28亿 USD | 10.87亿 USD |
| 销货成本 | 5.14亿 USD | 5.03亿 USD | 5.01亿 USD | 5.02亿 USD | 4.66亿 USD |
| 毛利 | 5.75亿 USD | 6.34亿 USD | 6.24亿 USD | 6.25亿 USD | 6.21亿 USD |
| 销售、一般及管理费用 | 2.65亿 USD | 2.64亿 USD | 2.59亿 USD | 2.52亿 USD | 2.65亿 USD |
| 营业费用 | 2.65亿 USD | 2.98亿 USD | 2.82亿 USD | 6.48亿 USD | 2.91亿 USD |
| 利息支出 | 4233.9万 USD | 4763.2万 USD | 6716万 USD | 6916.4万 USD | 6428.7万 USD |
| 折旧和摊销 | 3127.3万 USD | 3017.3万 USD | 3067.5万 USD | 3262.5万 USD | 3209.2万 USD |
| 营业利润 | 3.09亿 USD | 3.37亿 USD | 3.42亿 USD | −2241.5万 USD | 3.3亿 USD |
| 净利润 | 1.9亿 USD | 2.15亿 USD | 2.09亿 USD | −8230.6万 USD | 2.05亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$81.67
上涨空间 66.67%年度分割调整后的每股现金分配。
US$0.475
2018年(完整年度)+52.0% 自从 2013
US$0.3125
2,013
US$0.475
2,018
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2018年9月27日 | US$0.475Special | — | 2018年10月15日 |
股息 | 2013年12月27日 | US$0.3125Special | — | — |
除息 2018年9月27日
US$0.475
Special
支付日 2018年10月15日
除息 2013年12月27日
US$0.3125
Special
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI7846.7万0.00%2.3万亿 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM6014.81万0.08%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap ETFVB5635.89万0.03%1853亿 USD0.03%US$288.16-0.46%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV4004.74万0.15%268.09亿 USD0.33%US$37.98+0.08%
Vanguard Morningstar Small-Cap Value ETFVBR3584.28万0.05%682亿 USD0.05%US$234.71+0.12%
Vanguard Extended Market ETFVXF2847.02万0.03%954亿 USD0.05%US$233.52-0.63%
Dimensional - US Targeted Value ETFDFAT2126.65万0.07%301.22亿 USD0.33%US$67.42+0.22%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM2104.34万0.13%158.4亿 USD0.03%US$53.42-0.06%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
Dimensional - US Targeted Value ETFDFAT
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。